Abstract
Neuro-Oncology is defined as the study of primary and metastatic tumors of the central and peripheral nervous systems. The field of neuro-oncology can be divided into three general areas, based on location: (1) Brain (intra-axial tumors), (2) Skull base (extra-axial tumors), and (3) Spine tumors. From imaging modalities to radio- and chemo-therapeutics to optical technology, treatment and management of these tumors have greatly advanced, especially over the last hundred years. Advances in neuroimaging, in particular, have provided us with a better understanding of brain anatomy and its interaction with tumors, especially with relation to bone, cortex, vessels and white matter tracts. Since the time of Harvey Cushing, surgical management of CNS tumors have greatly improved with refinement in microsurgical techniques, optical technology (ie. loupes, stereoscopic microscopy, endoscope, and exoscope), and complementary treatment paradigms (ie. radiotherapy, chemotherapy, radiopharmaceuticals, and molecular therapies). As such, treatment of CNS tumors is complex and currently stands as a multidisciplinary endeavor, all in an effort to provide the best treatment for the patient. The historical contributions that have paved the way for our current understanding of neuro-oncological disease processes should not be overlooked. This chapter will briefly focus on the role scientists and physician-surgeons alike, have had in shaping neuro-oncology as a field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bhattacharyya KB. Harvey William Cushing: the father of modern neurosurgery (1869–1939). Neurol India. 2016;64(6):1125–8. https://doi.org/10.4103/0028-3886.193810.
Reed ME, Anthony PP, Rosenfeld PB, Ligon BL, Doris EM, Fox SW. Reflections on 50 years of neuroscience nursing: neuro-oncology, moving forward by looking Back. J Neurosci Nurs. 2018;50(3):124–8. https://doi.org/10.1097/JNN.0000000000000343.
Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro Oncol. 2019;21(Supplement 5):v1–v100. https://doi.org/10.1093/neuonc/noz150.
Brain GBD, Other CNSCC. Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(4):376–93. https://doi.org/10.1016/S1474-4422(18)30468-X.
Ndubaku U, de Bellard ME. Glial cells: old cells with new twists. Acta Histochem. 2008;110(3):182–95. https://doi.org/10.1016/j.acthis.2007.10.003.
Banan R, Hartmann C. The new WHO 2016 classification of brain tumors-what neurosurgeons need to know. Acta Neurochir. 2017;159(3):403–18. https://doi.org/10.1007/s00701-016-3062-3.
Conturo TE, Lori NF, Cull TS, Akbudak E, Snyder AZ, Shimony JS, et al. Tracking neuronal fiber pathways in the living human brain. Proc Natl Acad Sci U S A. 1999;96(18):10422–7.
Le Bihan DBE. Imagerie de diffusion in vivo par resonance magnetique nucleaire. Cr Acad Sci. 1985;93:27–34. https://doi.org/10.1016/0022-2364(85)90111-8.
Rutten GJ, Ramsey NF, van Rijen PC, van Veelen CW. Reproducibility of fMRI-determined language lateralization in individual subjects. Brain Lang. 2002;80(3):421–37. https://doi.org/10.1006/brln.2001.2600.
G PQ. Historia de la Neurocirugía. Rev Med Medicina. 2005;27:112–21.
Romero-Vargas S, Ruiz-Sandoval JL, Sotomayor-Gonzalez A, Revuelta-Gutierrez R, Celis-Lopez MA, Gomez-Amador JL, et al. A look at Mayan artificial cranial deformation practices: morphological and cultural aspects. Neurosurg Focus. 2010;29(6):E2. https://doi.org/10.3171/2010.9.FOCUS10200.
Gonen L, Chakravarthi SS, Monroy-Sosa A, Celix JM, Kojis N, Singh M, et al. Initial experience with a robotically operated video optical telescopic-microscope in cranial neurosurgery: feasibility, safety, and clinical applications. Neurosurg Focus. 2017;42(5):E9. https://doi.org/10.3171/2017.3.FOCUS1712.
Yasargil MG. A legacy of microneurosurgery: memoirs, lessons, and axioms. Neurosurgery. 1999;45(5):1025–92. https://doi.org/10.1097/00006123-199911000-00014.
Corsello A, Di Dalmazi G, Pani F, Chalan P, Salvatori R, Caturegli P, Walter E. Dandy: his contributions to pituitary surgery in the context of the overall Johns Hopkins Hospital experience. Pituitary. 2017;20(6):683–91. https://doi.org/10.1007/s11102-017-0834-6.
Ketcham AS, Wilkins RH, Vanburen JM, Smith RR. A combined intracranial facial approach to the paranasal sinuses. Am J Surg. 1963;106:698–703. https://doi.org/10.1016/0002-9610(63)90387-8.
House WF, Hitselberger WE. Transtemporal bone microsurgical removal of acoustic neuromas. Total versus subtotal removal of acoustic tumors. Arch Otolaryngol. 1964;80:751–2. https://doi.org/10.1001/archotol.1964.00750040767020.
Dolenc V. Direct microsurgical repair of intracavernous vascular lesions. J Neurosurg. 1983;58(6):824–31. https://doi.org/10.3171/jns.1983.58.6.0824.
Parkinson D. A surgical approach to the cavernous portion of the carotid artery. Anatomical studies and case report. J Neurosurg. 1965;23(5):474–83. https://doi.org/10.3171/jns.1965.23.5.0474.
Drake CG. Bleeding aneurysms of the basilar artery. Direct surgical management in four cases. J Neurosurg. 1961;18:230–8. https://doi.org/10.3171/jns.1961.18.2.0230.
Fisch U. Infratemporal fossa approach for glomus tumors of the temporal bone. Ann Otol Rhinol Laryngol. 1982;91(5 Pt 1):474–9. https://doi.org/10.1177/000348948209100502.
Al-Mefty O, Smith RR. Tailoring the cranio-orbital approach. Keio J Med. 1990;39(4):217–24. https://doi.org/10.2302/kjm.39.217.
Hakuba A, Liu S, Nishimura S. The orbitozygomatic infratemporal approach: a new surgical technique. Surg Neurol. 1986;26(3):271–6. https://doi.org/10.1016/0090-3019(86)90161-8.
Al-Mefty O, Fox JL, Smith RR. Petrosal approach for petroclival meningiomas. Neurosurgery. 1988;22(3):510–7. https://doi.org/10.1227/00006123-198803000-00010.
Sekhar LN, Ramanathan D. Evolution of far lateral and extreme lateral approaches to the skull base. World Neurosurg. 2012;77(5–6):617–8. https://doi.org/10.1016/j.wneu.2011.05.006.
Kawase T, Shiobara R, Toya S. Anterior transpetrosal-transtentorial approach for sphenopetroclival meningiomas: surgical method and results in 10 patients. Neurosurgery. 1991;28(6):869–75. discussion 75-6
Sen CN, Sekhar LN. An extreme lateral approach to intradural lesions of the cervical spine and foramen magnum. Neurosurgery. 1990;27(2):197–204. https://doi.org/10.1097/00006123-199008000-00004.
Sekhar LN, Sen CN, Lanzino G, Pomonis S. Carotid and cranial nerve reconstruction after removal of cavernous sinus lesions. Keio J Med. 1991;40(4):187–93. https://doi.org/10.2302/kjm.40.187.
Di Maio S, Ramanathan D, Garcia-Lopez R, Rocha MH, Guerrero FP, Ferreira M Jr, et al. Evolution and future of skull base surgery: the paradigm of skull base meningiomas. World Neurosurg. 2012;78(3–4):260–75. https://doi.org/10.1016/j.wneu.2011.09.004.
Doglietto F, Prevedello DM, Jane JA Jr, Han J, Laws ER Jr. Brief history of endoscopic transsphenoidal surgery--from Philipp Bozzini to the first world congress of endoscopic Skull Base surgery. Neurosurg Focus. 2005;19(6):1–6. https://doi.org/10.3171/foc.2005.19.6.4.
Kassam A, Snyderman CH, Mintz A, Gardner P, Carrau RL. Expanded endonasal approach: the rostrocaudal axis. Part I. Crista galli to the sella turcica. Neurosurg Focus. 2005;19(1):E3.
Kassam A, Snyderman CH, Mintz A, Gardner P, Carrau RL. Expanded endonasal approach: the rostrocaudal axis. Part II. Posterior clinoids to the foramen magnum. Neurosurg Focus. 2005;19(1):E4.
Duffau H. Stimulation mapping of myelinated tracts in awake patients. Brain Plast. 2016;2(1):99–113. https://doi.org/10.3233/BPL-160027.
Whitaker HA, Ojemann GA. Graded localisation of naming from electrical stimulation mapping of left cerebral cortex. Nature. 1977;270(5632):50–1.
Berger MS, Ojemann GA. Intraoperative brain mapping techniques in neuro-oncology. Stereotact Funct Neurosurg. 1992;58(1–4):153–61. https://doi.org/10.1159/000098989.
Duffau H, Capelle L, Sichez N, Denvil D, Lopes M, Sichez JP, et al. Intraoperative mapping of the subcortical language pathways using direct stimulations. An anatomo-functional study. Brain. 2002;125(Pt 1):199–214.
Kelly PJ, Kall BA, Goerss S. Transposition of volumetric information derived from computed tomography scanning into stereotactic space. Surg Neurol. 1984;21(5):465–71. https://doi.org/10.1016/0090-3019(84)90452-x.
Reinhardt H, Meyer H, Amrein E. A computer-assisted device for the intraoperative CT-correlated localization of brain tumors. Eur Surg Res. 1988;20(1):51–8. https://doi.org/10.1159/000128741.
Acerbi F, Cavallo C, Broggi M, Cordella R, Anghileri E, Eoli M, et al. Fluorescein-guided surgery for malignant gliomas: a review. Neurosurg Rev. 2014;37(4):547–57. https://doi.org/10.1007/s10143-014-0546-6.
Bentivoglio M, Kristensson K. Tryps and trips: cell trafficking across the 100-year-old blood-brain barrier. Trends Neurosci. 2014;37(6):325–33. https://doi.org/10.1016/j.tins.2014.03.007.
Wilson WL. De la Garza JG. Systemic chemotherapy for SNC metastase in solid tumors. Arch Intern Med. 1965;125
Sasmita AO, Wong YP, Ling APK. Biomarkers and therapeutic advances in glioblastoma multiforme. Asia Pac J Clin Oncol. 2018;14(1):40–51. https://doi.org/10.1111/ajco.12756.
Kim MM, Umemura Y, Leung D. Bevacizumab and glioblastoma: past, present, and future directions. Cancer J. 2018;24(4):180–6. https://doi.org/10.1097/PPO.0000000000000326.
Sampson JH, Maus MV, June CH. Immunotherapy for Brain tumors. J Clin Oncol. 2017;35(21):2450–6. https://doi.org/10.1200/JCO.2017.72.8089.
Farber SH, Elsamadicy AA, Atik AF, Suryadevara CM, Chongsathidkiet P, Fecci PE, et al. The safety of available immunotherapy for the treatment of glioblastoma. Expert Opin Drug Saf. 2017;16(3):277–87. https://doi.org/10.1080/14740338.2017.1273898.
Weller M, Stupp R, Hegi ME, van den Bent M, Tonn JC, Sanson M, et al. Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice. Neuro Oncol. 2012;14(Suppl 4):iv100–8. https://doi.org/10.1093/neuonc/nos206.
Lee M, Kim YS, Lee K, Kang M, Shin H, Oh JW, et al. Novel semi-replicative retroviral vector mediated double suicide gene transfer enhances antitumor effects in patient-derived glioblastoma models. Cancers (Basel). 2019;11(8) https://doi.org/10.3390/cancers11081090.
Acknowledgement
All this information has motivated us to write this book and a special thank you to Springer-Verlag editorial group, who has accepted to publish our experience, adding, of course, updated information in neuro-oncology, including biological biomarkers that are used for therapeutic decisions, the immunotherapy avatars, the genetic therapy and new techniques for administration of intrathecal or interstitial chemotherapy. Furthermore, we cite innovative robotic surgery techniques, as well as awake brain surgery, active surveillance and complementary treatment.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
de la Garza-Salazar, J.G., Juarez-Sánchez, P., Arrieta-Rodríguez, O., Chakravarthi, S.S., Monroy-Sosa, A. (2021). History of Neuro-Oncology: Towards a New Frontier. In: Monroy-Sosa, A., Chakravarthi, S.S., de la Garza-Salazar, J.G., Meneses Garcia, A., Kassam, A.B. (eds) Principles of Neuro-Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-54879-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-54879-7_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-54878-0
Online ISBN: 978-3-030-54879-7
eBook Packages: MedicineMedicine (R0)